Observational Study Following People With Chronic Hepatitis B in Jiangsu
Follows people with chronic hepatitis B to learn what affects how the infection progresses.
Plain-language title generated from the registry record
Registry title: "Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
Key facts
- Where
- Changzhou, Huai'an, Nanjing, Suqian, and Suzhou, ChinaSee the 6 sites
Where in China
- The Third Hospital of ChangzhouChangzhou, ChinaTaking people
- Huai'an No.4 People's HospitalHuai'an, ChinaTaking people
- Nanjing Jiangbei People's HospitalNanjing, ChinaTaking people
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNanjing, ChinaTaking people
- Suqian People's HospitalSuqian, ChinaTaking people
- The Fifth People's Hospital of SuzhouSuzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Trial code
- NCT03097952
- Record updated
- 31 March 2017
- Original description
Hepatitis B virus (HBV) infection remains one of the most serious health problems worldwide. Patients with chronic HBV infection are at an increased risk for developing hepatic cirrhosis, hepatocellular carcinoma and even death. Although some predictive factors of the outcome of chronic HBV infection were identified, more precisely determine the factors which are associated with the outcome in non-selected patients with chronic HBV infection are still needed. The investigators purpose is to constitute a observational cohort of non-selected Chinese patients to create a database of epidemiological, clinical, biological, virological, immunologic and therapeutic parameters, in order to determine factors associated with the outcome of chronic HBV infection.Read full original descriptionShow less
"Real-life" Cohort Study on Patients With Chronic Hepatitis B Virus Infection in Jiangsu
Hepatitis B virus (HBV) infection remains one of the most serious health problems worldwide. Patients with chronic HBV infection are at an increased risk for developing hepatic cirrhosis, hepatocellular carcinoma and even death. Although some predictive factors of the outcome of chronic HBV infection were identified, more precisely determine the factors which are associated with the outcome in non-selected patients with chronic HBV infection are still needed. The investigators purpose is to constitute a observational cohort of non-selected Chinese patients to create a database of epidemiological, clinical, biological, virological, immunologic and therapeutic parameters, in order to determine factors associated with the outcome of chronic HBV infection.
Inclusion: Patients with chronic HBV infection (defined as HBsAg positive for at least 6 months).
Exclusion: Co-infection with human immunodeficiency virus (HIV), hepatitis C virus (HCV) and/or hepatitis D virus (HDV); History of liver transplantation; History of hepatocellular carcinoma (HCC).